The U.S. Food and Drug Administration said it is committed to animal welfare in research by reducing, replacing and/or refining the use of animals in research, whenever possible.
In a statement, the agency said it is taking a step today to propose a study that, once completed, could provide a way for animal drug developers to conduct certain types of research without the use of dogs.
The aim is this: by doing a single study to help establish a non-animal based model, the FDA can potentially replace much of the need to use dogs in future trials with new informatics tools.
In short, FDA’s goal is to do one single study involving a small number of dogs—where the dogs will only be subject to minimally invasive blood sampling, and adopted as pets at the completion of the short trial—to eliminate the need for the use of dogs in certain types of future studies, some where they might have been euthanized.
The proposed study is part of the FDA’s overall efforts to help reduce reliance on animals used for research conducted by the agency’s scientists, as well as research conducted by industry.
In fact, if validated, this study could provide a new tool for animal drug developers to use in their own research for certain products and help them generate data in support of applications submitted to the agency without the use of animals.
The agency said it is optimistic that cultivating these types of new research approaches can help continue to reduce the need for animal testing.
Find out more at www.fda.gov.